Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 408.93 Million CNY | 14.54% |
| 2022 | 348.77 Million CNY | 23.18% |
| 2021 | 283.13 Million CNY | 44.77% |
| 2020 | 195.57 Million CNY | 26.47% |
| 2019 | 154.63 Million CNY | 32.64% |
| 2018 | 116.58 Million CNY | 11.07% |
| 2017 | 104.96 Million CNY | -10.06% |
| 2016 | 116.7 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 141.7 Million CNY | 51.6% |
| 2024 Q3 | 108.62 Million CNY | -24.11% |
| 2024 Q1 | 93.47 Million CNY | 42.74% |
| 2023 Q3 | 107.54 Million CNY | -24.52% |
| 2023 Q1 | 84 Million CNY | 12.76% |
| 2023 FY | 399.5 Million CNY | 14.54% |
| 2023 Q4 | 65.48 Million CNY | -39.11% |
| 2023 Q2 | 142.47 Million CNY | 69.61% |
| 2022 Q3 | 93.13 Million CNY | -23.64% |
| 2022 Q2 | 121.96 Million CNY | 106.1% |
| 2022 Q1 | 59.17 Million CNY | -10.73% |
| 2022 FY | 348.77 Million CNY | 23.18% |
| 2022 Q4 | 74.49 Million CNY | -20.02% |
| 2021 Q3 | 79.43 Million CNY | -10.45% |
| 2021 FY | 283.13 Million CNY | 44.77% |
| 2021 Q4 | 66.29 Million CNY | -16.55% |
| 2021 Q2 | 88.71 Million CNY | 82.2% |
| 2021 Q1 | 48.68 Million CNY | 7.06% |
| 2020 Q4 | 45.47 Million CNY | -24.96% |
| 2020 Q3 | 60.6 Million CNY | 13.85% |
| 2020 Q1 | 36.25 Million CNY | -14.3% |
| 2020 FY | 195.57 Million CNY | 26.47% |
| 2020 Q2 | 53.23 Million CNY | 46.83% |
| 2019 Q2 | 45.78 Million CNY | 92.75% |
| 2019 FY | 154.63 Million CNY | 32.64% |
| 2019 Q4 | 42.3 Million CNY | -1.15% |
| 2019 Q3 | 42.79 Million CNY | -6.52% |
| 2019 Q1 | 23.75 Million CNY | -26.13% |
| 2018 Q4 | 32.15 Million CNY | 0.0% |
| 2018 FY | 116.58 Million CNY | 11.07% |
| 2017 FY | 104.96 Million CNY | -10.06% |
| 2016 FY | 116.7 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 122.3 Million CNY | -234.348% |